论文部分内容阅读
Objective: To compare the clinical efficacy of Gongliuqing Capsule (宫瘤清胶囊) combined with mifepristone, Guizhi Fuling Capsule (桂枝茯苓胶囊) combined with mifepristone, and single mifepristone in the treatment of uterine fibroids. Methods: Retrospective analysis was performed on 307 patients with uterine fibroids receiving drug treatment in our hospital. All 307 patients has been divided into three groups according to the different drug delivery scheme, GLM group of 125 patients taking Gongliuqing Capsule and mifepristone, GFM group of 113 patients taking Guizhi Fuling Capsule (桂枝茯苓胶囊) and mifepristone, SM group of 69 patients only taking mifepristone. Comparison of the cure rate and effective rate, volume of menstruation, menstrual period and uterine fibroids, level of estrogen and the incidence of adverse reaction of the patients of the 3 groups. Results: After 90days of treatment, the efficiency of GLM and GFM group were higher than that of SM group (P0.05). The cure rate of GLM group was higher than that of the other two groups, and the difference was statistically significant (P0.05). Conclusions: Compared with the SM to treat uterine fibroids, the integrative medicine therapy were better. Among them, Gongliuqing Capsule (宫瘤清胶囊) combined with mifepristone has the highest cure rate.